| Date | Time | Source | Headline | Symbol | Company |
| 03/05/2019 | 21:36 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 26/04/2019 | 21:53 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 24/04/2019 | 16:58 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 24/04/2019 | 16:56 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 24/04/2019 | 16:55 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 24/04/2019 | 16:53 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 24/04/2019 | 16:52 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 24/04/2019 | 16:50 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 23/04/2019 | 21:19 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 23/04/2019 | 21:18 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 23/04/2019 | 21:18 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 23/04/2019 | 21:17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 23/04/2019 | 21:17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 23/04/2019 | 21:17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 23/04/2019 | 21:17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 23/04/2019 | 21:17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 23/04/2019 | 21:16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 23/04/2019 | 14:28 | GlobeNewswire Inc. | Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Completion of the Merger with OncoMed Pharmaceuticals, ... | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 23/04/2019 | 14:01 | Edgar (US Regulatory) | Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ... | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 18/04/2019 | 07:00 | GlobeNewswire Inc. | Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Merger Update: Acquisition of OncoMed Pharmaceuticals, In... | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 17/04/2019 | 20:27 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 17/04/2019 | 20:25 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 20/03/2019 | 21:06 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 15/03/2019 | 20:42 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 15/03/2019 | 12:35 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 15/03/2019 | 11:20 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 15/03/2019 | 11:20 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 15/03/2019 | 11:00 | GlobeNewswire Inc. | OncoMed Pharmaceuticals Declares Special Dividend of Contingent Value Rights | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 12/03/2019 | 13:28 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 07/03/2019 | 21:41 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |